Table of Contents  
ERRATUM
Year : 2015  |  Volume : 6  |  Issue : 2  |  Page : 122  

Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum


Date of Web Publication20-Apr-2015

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.155497

Rights and Permissions

How to cite this article:
. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum. J Pharmacol Pharmacother 2015;6:122

How to cite this URL:
. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum. J Pharmacol Pharmacother [serial online] 2015 [cited 2019 Sep 21];6:122. Available from: http://www.jpharmacol.com/text.asp?2015/6/2/122/155497

Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum

In the article, "Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study", which appeared in vol. 6, issue 1, pages 30-33 of Journal of Pharmacology and Pharmacotherapeutics, [1] the abbreviation in [Table 1], at page 31, is incorrectly written as CTACE instead of CTCAE for the expansion of Common Terminology Criteria for Adverse Events.

This has now been corrected and reposted online.

 
   References Top

1.
Francis J, Palaniappan M, Dubashi B, Pradhan SC, Chandrasekaran A. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study. J Pharmacol Pharmacother 2015;6:30-3.  Back to cited text no. 1
[PUBMED]  Medknow Journal  




 

Top
  
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1976    
    Printed47    
    Emailed0    
    PDF Downloaded180    
    Comments [Add]    

Recommend this journal